SCHEMBL8225786

SCHEMBL8225786

NC[C@H]1COc2cc(F)cc(-c3ccccc3OC(F)(F)F)c2O1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AQP1 P29972 1/20 0.36
SCN9A Q15858 5/20 0.34
CTSA P10619 2/20 0.34
S1PR1 P21453 1/20 0.33
CA2 P00918 1/20 0.33
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
BACE1 P56817 1/20 0.33
PRKAB2 O43741 1/20 0.32
PRKAG1 P54619 1/20 0.32
PRKAA2 P54646 1/20 0.32
PRKAA1 Q13131 1/20 0.32
PRKAG3 Q9UGI9 1/20 0.32
PRKAG2 Q9UGJ0 1/20 0.32
PRKAB1 Q9Y478 1/20 0.32
TRPA1 O75762 1/20 0.32
CYP19A1 P11511 1/20 0.32
GRM5 P41594 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14364276 0.87 HTR7 (0.42) AQP1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL8225988 0.86 ADRA1D (0.36) SCN9ACA2
SCHEMBL8225783 0.83 AQP1 (0.38) AQP1CA2PRKAB2PRKAG1PRKAA2
SCHEMBL14364285 0.83 AQP1 (0.41) AQP1CA2PRKAB2PRKAG1PRKAA2
SCHEMBL8225713 0.81 AQP1 (0.40) AQP1CA2PRKAB2PRKAG1PRKAA2
SCHEMBL8225982 0.81 AQP1 (0.50) AQP1CA2PRKAB2PRKAG1PRKAA2
SCHEMBL8203020 0.80 AQP1 (0.43) AQP1SCN9ACTSAS1PR1ALOX5AP
SCHEMBL8220449 0.80 SLC6A4 (0.43) AQP1CA2
SCHEMBL14364282 0.79 AQP1 (0.39) AQP1CA2PRKAB2PRKAG1PRKAA2
SCHEMBL8221231 0.79 AQP1 (0.41) AQP1CA2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007123942-A2 BENZODIOXANE AND BENZODIOXOLANE DERIVATIVES AND USES THEREOF WYETH (US) 2007-11-01 WO disclosed
US-20070255065-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2007-11-01 US disclosed
US-20070255065-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2007-11-01 US disclosed
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2006-10-26 US disclosed
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof WYETH (US) 2006-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241172-A1 Benzodioxane and benzodioxolane derivatives and uses thereof HTR2C, HTR1D, HTR1A AQP1 1697/4885SCN9A 1023/4885CTSA 4268/4885
US-20070255065-A1 Benzodioxane and benzodioxolane derivatives and uses thereof TBXA2R, HTR2C, NPY1R AQP1 2199/4885SCN9A 1754/4885CTSA 4324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.